These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19227798)
1. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Berman EP Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798 [TBL] [Abstract][Full Text] [Related]
2. Patents, profits, and the American people--the Bayh-Dole Act of 1980. Markel H N Engl J Med; 2013 Aug; 369(9):794-6. PubMed ID: 23984726 [No Abstract] [Full Text] [Related]
4. Technology transfer at US universities: seeking public benefit from the results of basic research. Goodwin CD Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243 [TBL] [Abstract][Full Text] [Related]
5. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act. Colaianni A; Cook-Deegan R Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286 [TBL] [Abstract][Full Text] [Related]
6. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms. Sarpatwari A; Kesselheim AS; Cook-Deegan R J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952 [TBL] [Abstract][Full Text] [Related]
7. Intellectual property. University licensing and the Bayh-Dole Act. Thursby JG; Thursby MC Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996 [No Abstract] [Full Text] [Related]
8. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act. Silva PJ; Ramos KS Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523 [TBL] [Abstract][Full Text] [Related]
9. March-in rights under the Bayh-Dole Act: the NIH's paper tiger? O'Brien W Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083 [No Abstract] [Full Text] [Related]
10. Patenting the PKU test--federally funded research and intellectual property. Paul DB; Ankeny RA N Engl J Med; 2013 Aug; 369(9):792-4. PubMed ID: 23984725 [No Abstract] [Full Text] [Related]
11. University-based science and biotechnology products: defining the boundaries of intellectual property. Kesselheim AS; Avorn J JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775 [TBL] [Abstract][Full Text] [Related]
12. Research and the Bayh-Dole Act. Reczek PR Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412 [No Abstract] [Full Text] [Related]
13. Patenting university research. Harry Steenbock and the Wisconsin Alumni Research Foundation. Apple RD Isis; 1989 Sep; 80(303):375-94. PubMed ID: 2681051 [No Abstract] [Full Text] [Related]
14. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business. Fernandes M; Miska D Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036 [No Abstract] [Full Text] [Related]
15. Bayh-Dole: if we knew then what we know now. Boettiger S; Bennett AB Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405 [No Abstract] [Full Text] [Related]
16. Gene patenting and licensing: the role of academic researchers and advocacy groups. Ledbetter DH Genet Med; 2008 May; 10(5):314-9. PubMed ID: 18496028 [TBL] [Abstract][Full Text] [Related]
17. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study. Treasure CL; Avorn J; Kesselheim AS Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985 [TBL] [Abstract][Full Text] [Related]
18. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing. Leute K Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475 [TBL] [Abstract][Full Text] [Related]